Trial intelligence / Profile preview

PULSE-MI: Pulse Glucocorticoid Therapy in STEMI

NCT05462730Phase 2Completed

Start
Nov 2022
Primary completion
Jan 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methylprednisolone injection in ST elevation myocardial infarction (STEMI). Started Nov 2022; status: completed.

02

Drugs

methylprednisolone injection
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT05462730.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05462730.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call